BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Suomalainen A. Therapy for mitochondrial disorders: little proof, high research activity, some promise. Semin Fetal Neonatal Med 2011;16:236-40. [PMID: 21676668 DOI: 10.1016/j.siny.2011.05.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Markin AM, Khotina VA, Zabudskaya XG, Bogatyreva AI, Starodubova AV, Ivanova E, Nikiforov NG, Orekhov AN. Disturbance of Mitochondrial Dynamics and Mitochondrial Therapies in Atherosclerosis. Life (Basel) 2021;11:165. [PMID: 33672784 DOI: 10.3390/life11020165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell 2012;148:1145-59. [PMID: 22424226 DOI: 10.1016/j.cell.2012.02.035] [Cited by in Crossref: 1455] [Cited by in F6Publishing: 1395] [Article Influence: 145.5] [Reference Citation Analysis]
3 Dard L, Blanchard W, Hubert C, Lacombe D, Rossignol R. Mitochondrial functions and rare diseases. Mol Aspects Med 2020;71:100842. [PMID: 32029308 DOI: 10.1016/j.mam.2019.100842] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
4 Hurko O. Drug development for rare mitochondrial disorders. Neurotherapeutics 2013;10:286-306. [PMID: 23430661 DOI: 10.1007/s13311-013-0179-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
5 Khan NA, Govindaraj P, Meena AK, Thangaraj K. Mitochondrial disorders: challenges in diagnosis & treatment. Indian J Med Res 2015;141:13-26. [PMID: 25857492 DOI: 10.4103/0971-5916.154489] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
6 Caicedo A, Aponte PM, Cabrera F, Hidalgo C, Khoury M. Artificial Mitochondria Transfer: Current Challenges, Advances, and Future Applications. Stem Cells Int 2017;2017:7610414. [PMID: 28751917 DOI: 10.1155/2017/7610414] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 8.6] [Reference Citation Analysis]
7 Matilainen S, Isohanni P, Euro L, Lönnqvist T, Pihko H, Kivelä T, Knuutila S, Suomalainen A. Mitochondrial encephalomyopathy and retinoblastoma explained by compound heterozygosity of SUCLA2 point mutation and 13q14 deletion. Eur J Hum Genet 2015;23:325-30. [PMID: 24986829 DOI: 10.1038/ejhg.2014.128] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
8 Kanabus M, Heales SJ, Rahman S. Development of pharmacological strategies for mitochondrial disorders. Br J Pharmacol 2014;171:1798-817. [PMID: 24116962 DOI: 10.1111/bph.12456] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
9 Jackson CB, Bauer MF, Schaller A, Kotzaeridou U, Ferrarini A, Hahn D, Chehade H, Barbey F, Tran C, Gallati S, Haeberli A, Eggimann S, Bonafé L, Nuoffer J. A novel mutation in BCS1L associated with deafness, tubulopathy, growth retardation and microcephaly. Eur J Pediatr 2016;175:517-25. [DOI: 10.1007/s00431-015-2661-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
10 Lee IC, Chiang KL. Clinical Diagnosis and Treatment of Leigh Syndrome Based on SURF1: Genotype and Phenotype. Antioxidants (Basel) 2021;10:1950. [PMID: 34943053 DOI: 10.3390/antiox10121950] [Reference Citation Analysis]
11 Spath K, Babariya D, Konstantinidis M, Lowndes J, Child T, Grifo JA, Poulton J, Wells D. Clinical application of sequencing-based methods for parallel preimplantation genetic testing for mitochondrial DNA disease and aneuploidy. Fertil Steril 2021;115:1521-32. [PMID: 33745725 DOI: 10.1016/j.fertnstert.2021.01.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Jestin M, Kapnick SM, Tarasenko TN, Burke CT, Zerfas PM, Diaz F, Vernon H, Singh LN, Sokol RJ, McGuire PJ. Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity. Mol Metab 2020;37:100981. [PMID: 32283081 DOI: 10.1016/j.molmet.2020.100981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Kam A, Loo S, Dutta B, Sze SK, Tam JP. Plant-derived mitochondria-targeting cysteine-rich peptide modulates cellular bioenergetics. J Biol Chem 2019;294:4000-11. [PMID: 30674551 DOI: 10.1074/jbc.RA118.006693] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
14 Yatsuga S, Suomalainen A. Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice. Hum Mol Genet 2012;21:526-35. [PMID: 22012983 DOI: 10.1093/hmg/ddr482] [Cited by in Crossref: 85] [Cited by in F6Publishing: 80] [Article Influence: 7.7] [Reference Citation Analysis]
15 El-Khoury R, Kemppainen KK, Dufour E, Szibor M, Jacobs HT, Rustin P. Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives. Br J Pharmacol 2014;171:2243-9. [PMID: 24383965 DOI: 10.1111/bph.12570] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
16 Suomalainen A, Battersby BJ. Mitochondrial diseases: the contribution of organelle stress responses to pathology. Nat Rev Mol Cell Biol 2018;19:77-92. [DOI: 10.1038/nrm.2017.66] [Cited by in Crossref: 175] [Cited by in F6Publishing: 156] [Article Influence: 35.0] [Reference Citation Analysis]
17 Schiff M, Bénit P, El-Khoury R, Schlemmer D, Benoist JF, Rustin P. Mouse studies to shape clinical trials for mitochondrial diseases: high fat diet in Harlequin mice. PLoS One 2011;6:e28823. [PMID: 22174907 DOI: 10.1371/journal.pone.0028823] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
18 Lee WS, Sokol RJ. Mitochondrial hepatopathies: advances in genetics, therapeutic approaches, and outcomes. J Pediatr 2013;163:942-8. [PMID: 23810725 DOI: 10.1016/j.jpeds.2013.05.036] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 3.9] [Reference Citation Analysis]
19 Fabbri A, Travaglione S, Maroccia Z, Guidotti M, Pierri CL, Primiano G, Servidei S, Loizzo S, Fiorentini C. The Bacterial Protein CNF1 as a Potential Therapeutic Strategy against Mitochondrial Diseases: A Pilot Study. Int J Mol Sci 2018;19:E1825. [PMID: 29933571 DOI: 10.3390/ijms19071825] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
20 Pearson RM, Hsu H, Bugno J, Hong S. Understanding nano-bio interactions to improve nanocarriers for drug delivery. MRS Bull 2014;39:227-37. [DOI: 10.1557/mrs.2014.9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
21 Akdoğan E, Tardu M, Garipler G, Baytek G, Kavakli İH, Dunn CD. Reduced Glucose Sensation Can Increase the Fitness of Saccharomyces cerevisiae Lacking Mitochondrial DNA. PLoS One 2016;11:e0146511. [PMID: 26751567 DOI: 10.1371/journal.pone.0146511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
22 Toriello HV. Approach to the Genetic Evaluation of the Child with Autism. Pediatric Clinics of North America 2012;59:113-28. [DOI: 10.1016/j.pcl.2011.10.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
23 Shi X, Zhao M, Fu C, Fu A. Intravenous administration of mitochondria for treating experimental Parkinson's disease. Mitochondrion 2017;34:91-100. [PMID: 28242362 DOI: 10.1016/j.mito.2017.02.005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 9.6] [Reference Citation Analysis]
24 McInnes J. Mitochondrial-associated metabolic disorders: foundations, pathologies and recent progress. Nutr Metab (Lond) 2013;10:63. [PMID: 24499129 DOI: 10.1186/1743-7075-10-63] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
25 Beilschmidt LK, Puccio HM. Mammalian Fe-S cluster biogenesis and its implication in disease. Biochimie 2014;100:48-60. [PMID: 24440636 DOI: 10.1016/j.biochi.2014.01.009] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 8.3] [Reference Citation Analysis]
26 Khan NA, Auranen M, Paetau I, Pirinen E, Euro L, Forsström S, Pasila L, Velagapudi V, Carroll CJ, Auwerx J, Suomalainen A. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol Med 2014;6:721-31. [PMID: 24711540 DOI: 10.1002/emmm.201403943] [Cited by in Crossref: 240] [Cited by in F6Publishing: 221] [Article Influence: 34.3] [Reference Citation Analysis]
27 Uittenbogaard M, Chiaramello A. Maternally inherited mitochondrial respiratory disorders: from pathogenetic principles to therapeutic implications. Mol Genet Metab 2020;131:38-52. [PMID: 32624334 DOI: 10.1016/j.ymgme.2020.06.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Komen JC, Thorburn DR. Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models. Br J Pharmacol 2014;171:1818-36. [PMID: 24102298 DOI: 10.1111/bph.12413] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 10.4] [Reference Citation Analysis]